AGEN
AGENUS INC
NASDAQ · Healthcare · Biotechnology · US
$6.97
+4.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 25.87x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.57x
- PEG TTM
- —
- Price / book
- -1.58x
- Price / sales
- 2.37x
- Price / cash flow
- -3.20x
Enterprise value
- Enterprise value
- $330.0M
- EV / sales
- 2.49x
- EV / EBITDA
- 2.12x
- EV / EBIT
- 9.12x
- Market cap
- $314.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026